Cargando…
Factors associated with improved outcome of inhaled corticosteroid use in COVID-19: A single institutional study
Asthmatics seem less prone to adverse outcomes in coronavirus disease 2019 (COVID-19) and some data shows that inhaled corticosteroids (ICS) are protective. We gathered data on anecdotal ICS and outcomes of patients hospitalized with COVID-19, given there is literature supporting ICS may reduce risk...
Autores principales: | Manfra, Andrew, Chen, Claire, Batra, Kavita, Min Tun, Kyaw, Kioka, Mutsumi John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794212/ https://www.ncbi.nlm.nih.gov/pubmed/36595838 http://dx.doi.org/10.1097/MD.0000000000032420 |
Ejemplares similares
-
Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study
por: Lee, Ming-Chia, et al.
Publicado: (2015) -
Factors associated with the appropriate use of ultra-broad spectrum antibiotics, meropenem, for suspected healthcare-associated pneumonia
por: Kirsch, Nathan, et al.
Publicado: (2021) -
Inhaled Corticosteroids Use Is Not Associated With an Increased Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus: Two Nested Case-Control Studies
por: Lee, Chang-Hoon, et al.
Publicado: (2016) -
Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study
por: Wei, Ping, et al.
Publicado: (2016) -
Comparing demographics, clinical characteristics, and hospital outcomes by vaccine uptake status: A single-institution cross-sectional study
por: Chen, Claire Xinning, et al.
Publicado: (2023)